The CRO built for
medical device success.
From first submission to post-market approval. Built around how devices get to market.
From first submission to post-market approval. Built around how devices get to market.
Because your device deserves to reach the patients who need it.
Because your device deserves to reach the patients who need it.
The problem
Most CROs were built for drug trials. The frameworks, the pricing models, the study designs. All of it was built around a linear, phase-based process that has little to do with how medical devices actually reach patients. The result is device companies forced to work within a system that was never designed for them, losing time and money adapting to a mold that does not fit.
Device programs are different
Timelines are tied to engineering cycles, not phase gates. Regulatory pathways branch depending on device class, intended use, and market. Endpoints have to capture how real people interact with a product in real environments. These are not minor differences. They change how a trial should be designed, staffed, priced, and run from the ground up.
There is a better way
Device companies should not have to compromise. A CRO that knows 510(k) from De Novo from PMA. That designs protocols around your device. That structures engagements around milestones, not headcount. That understands your engineering cycles and stays with your program through every stage.
Built for the modern era
From study design through to execution, we bring AI and purpose built tools into a single path, so your program moves faster and your team spends less time on the work that should not require their attention.
Get in touch
If you are working on a device program and want a CRO that was built for it, we would like to hear from you.
The problem
Most CROs were built for drug trials. The frameworks, the pricing models, the study designs. All of it was built around a linear, phase-based process that has little to do with how medical devices actually reach patients. The result is device companies forced to work within a system that was never designed for them, losing time and money adapting to a mold that does not fit.
Device programs are different
Timelines are tied to engineering cycles, not phase gates. Regulatory pathways branch depending on device class, intended use, and market. Endpoints have to capture how real people interact with a product in real environments. These are not minor differences. They change how a trial should be designed, staffed, priced, and run from the ground up.
There is a better way
Device companies should not have to compromise. A CRO that knows 510(k) from De Novo from PMA. That designs protocols around your device. That structures engagements around milestones, not headcount. That understands your engineering cycles and stays with your program through every stage.
From study design to execution
From study design through to execution, we bring AI and purpose built tools into a single path, so your program moves faster and your team spends less time on the work that should not require their attention.
Get in touch
If you are working on a device program and want a CRO that was built for it, we would like to hear from you.